Back

Factor XI inhibition: clinical view on current research and future implications

30 August 2024 (15:40 - 15:55)
Organised by: Logo
Congress Presentation Part of: Advances in thrombosis management: evaluating current and emerging anticoagulation strategies Thrombosis, Platelets, and Coagulation Open Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
Welcome and Introductions
Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Slides Video
Presentation thumbnail
Contemporary thrombosis management -- state of the state
Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Slides Video
Presentation thumbnail
Factor XI inhibition uncoupled: mechanistic insights and rationale
Doctor J. Weitz (Hamilton, CA)
Slides Video
Presentation thumbnail
Program summary and conclusion
Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Slides Video

Access the full session

Session thumbnail
Advances in thrombosis management: evaluating current and emerging anticoagulation strategies
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 15:40 CET
You may be interested in
thumbnail
Congress Presentation
Shaping clinical practice and clinical trials
29 August 2025
thumbnail
Congress Presentation
OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation
1 September 2024
thumbnail
Congress Presentation
Cardiac electrophysiology research in Circulation
31 August 2025
thumbnail
Congress Presentation
First-in-human study to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of RBD4059, a GalNAc-siRNA drug targeting coagulation factor XI (FXI), in healthy subjects
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources